NRx Pharmaceuticals (NRXP) Earnings
|
Expand Research on NRXP
| Next EPS Date | 8/17/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +7.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/17/26  |
Q226 | N/A | -$0.05 | N/A | N/A | $10.11M | N/A | N/A | N/A | ||
| 5/18/26 | Q126 | $0.00 | $0.00 | $0.00 | $1.07M | N/A | N/A |  | | Details | |
| 8/18/25 |
Q225 | N/A | -$0.53 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/14/24 | Q124 | N/A | -$0.05 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/28/24 |
Q423 | N/A | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/14/23 | Q323 | -$0.07 | -$0.11 | +$0.04 | N/A | N/A | N/A | | | Details | |
| 8/14/23 | Q223 | -$0.12 | -$0.13 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 5/16/23 | Q123 | -$0.16 | -$0.14 | -$0.02 | N/A | N/A | N/A | | | Details |
